“We will continue until our final goal – islet transplantation without immunosuppression.”
Rodolfo Alejandro, M.D.
Rodolfo Alejandro, M.D., is a Professor of Medicine at the University of Miami Miller School of Medicine, and Co-Director of the Cell Transplant Center, and Director/Attending Physician of the Clinical Cell Transplant Program at the Diabetes Research Institute. Dr. Alejandro has overseen all facets of the Clinical Islet Transplant Program since the program began in 1985.
He has extensive experience in the field of islet isolation and transplantation, transplantation medicine, and endocrinology and metabolism (board certified in both internal medicine and endocrinology and metabolism). Dr. Alejandro has significantly contributed to the standardization of islet assessment with the introduction of a quick method for islet identification (dithizone staining), the use of Cobe cell processor for islet separation and islet purification. His observations in islet transplantation in preclinical models has helped spark the renewed interest in clinical islet transplantation trials.
An author and co-author of many works in the field of islet transplantation, Dr. Alejandro sits on numerous editorial boards and is the recipient of the Alpha Omega Alpha and the Pfizer Scholars Award in diabetes.
Islet Cell Transplantation Can Give Some Diabetics Long Term Glucose Control
National Institutes of Health: Pancreatic Islet Transplantation
A Decade of Freedom from Insulin Injections
Early Metabolic Markers of Islet Allograft Dysfunction
Phase I/II Clinical Trial Testing the Omentum
Quality of Life After Transplantation